Awakn Life Sciences (NEO: AWKN) (OTCQB: AWKNF) is a biotechnology\ncompany developing therapeutics treatring addiction. Awakn has a near-term focus on Alcohol Use Disorder (AUD), a condition affecting 285m people globally for which the current standard of care is inadequate.